Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Healthy volunteers test drug interactions for future diabetes care

NCT ID NCT07444424

First seen Mar 07, 2026 · Last updated Jun 15, 2026 · Updated 17 times

Summary

This study looks at how a new drug called AZD5004 changes the way the body handles two diabetes medications, mitiglinide and pioglitazone. It involves 32 healthy adults and does not aim to treat any disease. The goal is to gather safety and drug-level information to guide future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Research Site

    Fukuoka, 813-0017, Japan

Conditions

The condition(s) this trial relates to.

Obesity type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.